Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT03392428
Assets
Linked programs
- 177Lu-PSMA617: Operational Burden Signal (4/5)